Presented By: Center for Bioethics and Social Sciences in Medicine (CBSSM)
CBSSM Seminar with Lloyd Akrong, MSc (July 14th)-- Pls note different location!

International biomedical research: science, society, and pharmaceutical innovation & development
Lloyd Akrong, MSc
Research Fellow, Faculty of Health, Medicine and Life Sciences
Maastricht University
3:00-4:00 PM
Center for Bioethics and Social Sciences in Medicine
University of Michigan
2800 Plymouth Road
NCRC, Building 16, B001E
Ann Arbor, MI 48109-2800
Abstract: Biomedical research activities continue to spread across the globe. Evidence of this can been seen in the growing numbers of clinical trials being conducted in regions outside of the well-established research markets of Europe and North America. In addition, there has been a parallel move of research frameworks, including documents, protocols, guidelines and regulations, meant to guide the ethical conduct of international clinical trial research involving human subjects. However as more countries continue to claim a greater stake in the clinical trial arena, bringing diverse cultural norms, traditions and perspectives, as well as indigenous knowledge systems, beliefs and customs, there is a need to reflect on how international clinical trial conduct, collaboration, and local involvement in research and development is being (re)shaped and (re)envisioned. Furthermore to ensure that international research remains sustainable, while providing social value, we must seriously engage with the ways in which host countries and communities continue to establish themselves as relevant actors within the biomedical research environment. (Co-author: Olga Zvonareva)
Refreshments will be provided.
Lloyd Akrong, MSc
Research Fellow, Faculty of Health, Medicine and Life Sciences
Maastricht University
3:00-4:00 PM
Center for Bioethics and Social Sciences in Medicine
University of Michigan
2800 Plymouth Road
NCRC, Building 16, B001E
Ann Arbor, MI 48109-2800
Abstract: Biomedical research activities continue to spread across the globe. Evidence of this can been seen in the growing numbers of clinical trials being conducted in regions outside of the well-established research markets of Europe and North America. In addition, there has been a parallel move of research frameworks, including documents, protocols, guidelines and regulations, meant to guide the ethical conduct of international clinical trial research involving human subjects. However as more countries continue to claim a greater stake in the clinical trial arena, bringing diverse cultural norms, traditions and perspectives, as well as indigenous knowledge systems, beliefs and customs, there is a need to reflect on how international clinical trial conduct, collaboration, and local involvement in research and development is being (re)shaped and (re)envisioned. Furthermore to ensure that international research remains sustainable, while providing social value, we must seriously engage with the ways in which host countries and communities continue to establish themselves as relevant actors within the biomedical research environment. (Co-author: Olga Zvonareva)
Refreshments will be provided.